Argenx
ARGX
$368.60
Share price
-1.71%
Change (1 day)
-5.61%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Total assets
Total assets on the balance sheet as of December 2023 : $4.54 B
According to Argenx 's latest financial reports the company's total assets are $4.54 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Argenx - Total assets on balance sheet (from 2021 to 2020)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $3.13 B | 9.96% |
| 2021-12-31 | $2.85 B | 1.66% |
| 2020-12-31 | $2.80 B | 55.43% |
| 2019-12-31 | $1.80 B | 138.29% |
| 2018-12-31 | $0.75 B | 41.7% |
| 2017-12-31 | $0.53 B | 356.18% |
| 2016-12-31 | $0.11 B | 113.13% |
| 2015-12-31 | $54.94 M | -36.5% |
| 2014-12-31 | $86.53 M | 81.41% |
| 2013-12-31 | $47.69 M | 57.27% |
| 2012-12-31 | $30.33 M | -26.73% |
| 2011-12-31 | $41.39 M | 153.82% |
| 2010-12-31 | $16.3 M |